Caricamento...
An Update in Advanced Gastric Cancer: 2009
Overall survival in advanced gastric cancer has not changed significantly, despite two decades of multiple phase III studies. Debate is ongoing regarding whether doublet or triplet therapy is the best “standard” or platform regimen for the addition of a biologic or small-molecular targeted agents. H...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
International Society of Gastrointestinal Oncology
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3056308/ |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|